Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mitlak

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Annals of Internal Medicine|August 24, 1999
Update in endocrinologyH Heath, B Mitlak, P Anderson
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2022
Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database studyF Cosman, C Cooper, Y Wang, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 26, 2002
Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosisN H Bjarnason, S Sarkar, T Duong, et al.
Menopause (New York, N.Y.)|September 16, 1999
Endometrial response to raloxifene compared with placebo, cyclical hormone replacement therapy, and unopposed estrogen in postmenopausal womenG C Davies, W J Huster, W Shen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 16, 2020
Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trialN B Watts, R K Dore, S Baim, et al.
Calcified Tissue International|March 28, 2012
Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paperJ Goldhahn, J-M Féron, J Kanis, et al.
Calcified Tissue International|August 11, 2012
Management of glucocorticoid-induced osteoporosisR Rizzoli, J D Adachi, C Cooper, et al.
Bone|December 4, 2012
Treatment of osteoporosis in menJ-M Kaufman, J-Y Reginster, S Boonen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 1, 2012
Frailty and sarcopenia: definitions and outcome parametersC Cooper, W Dere, W Evans, et al.
Calcified Tissue International|July 12, 2013
Tools in the assessment of sarcopeniaC Cooper, R Fielding, M Visser, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Annals of Internal Medicine|August 24, 1999
Update in endocrinologyH Heath, B Mitlak, P Anderson
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2022
Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database studyF Cosman, C Cooper, Y Wang, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 26, 2002
Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosisN H Bjarnason, S Sarkar, T Duong, et al.
Menopause (New York, N.Y.)|September 16, 1999
Endometrial response to raloxifene compared with placebo, cyclical hormone replacement therapy, and unopposed estrogen in postmenopausal womenG C Davies, W J Huster, W Shen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 16, 2020
Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trialN B Watts, R K Dore, S Baim, et al.
Calcified Tissue International|March 28, 2012
Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paperJ Goldhahn, J-M Féron, J Kanis, et al.
Calcified Tissue International|August 11, 2012
Management of glucocorticoid-induced osteoporosisR Rizzoli, J D Adachi, C Cooper, et al.
Bone|December 4, 2012
Treatment of osteoporosis in menJ-M Kaufman, J-Y Reginster, S Boonen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 1, 2012
Frailty and sarcopenia: definitions and outcome parametersC Cooper, W Dere, W Evans, et al.
Calcified Tissue International|July 12, 2013
Tools in the assessment of sarcopeniaC Cooper, R Fielding, M Visser, et al.
Pageof 2